Seqera Labs is a bioinformatics company developing technologies for data pipelines, founded in 2018 in Barcelona.[1] It is a spin-off of the Centre for Genomic Regulation (CRG) founded by Evan Floden and Paolo di Tommaso and its services are largely related to the open-source software Nextflow, released in 2013.[1][2][3]
In 2022, the company raised 22 million euros in Series A funding.[4] It has also received several grants from the Chan Zuckerberg Initiative.[5]
^ abAllen, Patricia (2022-10-25). "Barcelona-based Seqera Labs secures €22 million to help power innovation in healthcare and life sciences". EU-Startups. Retrieved 2023-03-30.
^Lunden, Ingrid (2021-09-07). "Seqera Labs grabs $5.5M to help sequence COVID-19 variants and other complex data problems". TechCrunch. Retrieved 2023-03-30.
^Kliver, Jenny. "CRG spin-off Seqera Labs raises 22 million euros in Series A funding – Barcelona Institute of Science and Technology – BIST". Retrieved 2023-03-30.
SeqeraLabs is a bioinformatics company developing technologies for data pipelines, founded in 2018 in Barcelona. It is a spin-off of the Centre for Genomic...
license for Nextflow was changed from GPLv3 to Apache 2.0. In July 2018, SeqeraLabs was launched as a spin-off from the Centre for Genomic Regulation. The...
Silicon Valley (formerly Ingenuity Systems) Qlucore Phalanx Biotech Group SeqeraLabs SimBioSys created the eHITS software SRA International services aimed...